
CAS 1021868-76-7
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
6 produits concernés.
(+/-)-4-([3,4-DICHLOROBENZOYL]AMINO)-5-(DIPENTYLAMINO)-5-OXOPENTANOIC ACID SODIUM
CAS :Formule :C22H31Cl2N2NaO4Degré de pureté :99%Couleur et forme :SolidMasse moléculaire :481.3883Lorglumide sodium salt
CAS :Lorglumide sodium saltDegré de pureté :≥98%Masse moléculaire :481.39g/molLorglumide sodium salt
CAS :<p>Lorglumide sodium salt is a guanine nucleotide-binding protein that has low potency and is used as an experimental model for polymerase chain reaction. It interacts with the transcriptional regulator cck-a, which inhibits the production of estradiol benzoate, cortisol concentration, and energy metabolism. Lorglumide sodium salt also interacts with receptors to inhibit the activity of peptide hormones and carcinoma cell lines.</p>Formule :C22H31Cl2N2NaO4Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :481.39 g/molLorglumide Sodium Salt
CAS :Produit contrôlé<p>Stability Hygroscopic<br>Applications Lorglumide Sodium Salt is a nonpeptidic antagonist of the CCK A recepotor, and minimally effective at the CCK B receptor. It blocks CCK -mediated muscle contraction, pancreatic growth and secretion.<br>References Makovec, F. et al.: J. Med. Chem., 35, 28 (1992);<br></p>Formule :C22H31Cl2N2NaO4Couleur et forme :NeatMasse moléculaire :481.39Lorglumide sodium salt
CAS :Lorglumide sodium salt (CR-1409 sodium salt) is an antagonist of cholecystokinin receptors (CCK).Formule :C22H31Cl2N2NaO4Degré de pureté :99.32%Couleur et forme :SolidMasse moléculaire :481.39






